Who owns the CONFLUENCE trademark?

The CONFLUENCE trademark is owned by Aclaris Therapeutics, Inc..

What class is the CONFLUENCE trademark registered in?

The CONFLUENCE trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CONFLUENCE?

The USPTO serial number for CONFLUENCE is 98161571.

What is the registration number for CONFLUENCE?

CONFLUENCE is registered under USPTO registration number 7690845.

Sealvo

Home Search: CONFLUENCECONFLUENCE #98161571

Back

Updated Oct 25, 2026·9 searches this week

View on USPTO TSDR Find similar marks

CON

USPTO Trademark Record

REGISTERED

CONFLUENCE

SN 98161571·Reg 7690845·Filed Sep 01, 2023

Owner Aclaris Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CONFLUENCE (Serial No. 98161571), Registration No. 7690845, is a registered US trademark filed on Sep 01, 2023 by Aclaris Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: February 11, 2031

Mark Intelligence

CONFLUENCE (Reg. #7690845) is a registered US trademark that has been protecting its owner, Aclaris Therapeutics, Inc., since 2023. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Sep 01, 2023

SERIAL

98161571

REG#

7690845

REGISTERED

Feb 11, 2025

Filing Information

StatusREGISTERED

Filing DateSep 01, 2023

Serial Number98161571

Registration No.7690845

Registration DateFeb 11, 2025

Status DateFeb 11, 2025

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Aug 03, 2017

First use in commerce: Aug 03, 2017

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

31 events

REGISTERED-SUPPLEMENTAL REGISTER

Feb 11, 2025

REGISTERED-SUPPLEMENTAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 11, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Jan 23, 2025

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 22, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 22, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 22, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Dec 06, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 06, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 06, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 12, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 12, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 12, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Aug 26, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 26, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 26, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

USE AMENDMENT ACCEPTED

Aug 25, 2024

USE AMENDMENT ACCEPTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 31, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 31, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 31, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS AMENDMENT OF USE RECEIVED

Jul 30, 2024

TEAS AMENDMENT OF USE RECEIVED

USE AMENDMENT FILED

Jul 30, 2024

USE AMENDMENT FILED

AMENDMENT TO USE PROCESSING COMPLETE

Jul 30, 2024

AMENDMENT TO USE PROCESSING COMPLETE

NON-FINAL ACTION WRITTEN

May 03, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 03, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 03, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 30, 2024

ASSIGNED TO EXAMINER

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Nov 02, 2023

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 02, 2023

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 02, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 27, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 05, 2023

NEW APPLICATION ENTERED

Other Marks by Aclaris Therapeutics, Inc.

Additional USPTO filings from the same owner.

KIN

KINECT

88372841

Aclaris Therapeutics, Inc.

REGISTERED

ACL

ACLARIS

98161483

Aclaris Therapeutics, Inc.

REGISTERED

ACL

ACLARIS THERAPEUTICS

98161581

Aclaris Therapeutics, Inc.

REGISTERED

ACL

ACLARIS THERAPEUTICS

87036909

Aclaris Therapeutics, Inc.

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

CON

CONFLUENCE

88464693

Keri Systems, Inc.

REGISTERED

CON

CONFLUENCE

86891074

Atlassian Pty Ltd

REGISTERED

CON

CONFLUENCE

75938015

CONFLUENCE TECHNOLOGIES, INC.

REGISTERED

CON

CONFLUENCE

79061333

ATLASSIAN PTY LTD

REGISTERED

Other Marks by Michael A. Geller

Additional USPTO filings handled by the same attorney of record.

LUV

LUVIAS

86855117

REGISTERED

LIB

LIBOR

88705757

REGISTERED

SOL

SOLUTIONS BY TEXT

99402161

REGISTERED

MAT

MATTER

90593530

REGISTERED

CONFLUENCE

Run a conflict check

Other Marks by Aclaris Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Michael A. Geller

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company